PURPOSE: Keratoconus is a chronic, noninflammatory disease of the cornea with onset in
early adulthood. As these years are important to financial and social health, keratoconus may …

… Our group also has shown in preliminary analyses that PK patients report substantially
improved V-QoL, particularly after transplantation of the fellow eye (Kymes SM, et al. IOVS 2004;…

PURPOSE: To investigate whether there is an association between complement factor H (CFH)
or LOC387715 genotypes with response to treatment with intravitreal bevacizumab for …

CT and PET are widely used to characterize solitary pulmonary nodules (SPNs). However,
most CT accuracy studies have been performed with outdated technology and methods, and …

… Kymes nor any immediate family member has received anything of value from or has stock
or stock options held in a commercial company or institution related directly or indirectly to the …

Aims: To determine whether complement factor H (CFH) genotypes have a pharmacogenetic
effect on the treatment of exudative age-related macular degeneration (AMD) with …

PURPOSE:: To estimate the expected incremental lifetime cost of treatment of keratoconus
compared to the expected cost of the treatment of myopia. DESIGN:: Cost estimate from the …

PURPOSE: The Ocular Hypertension Treatment Study (OHTS) demonstrated that medical
treatment of people with intraocular pressure (IOP) of ≥24 mm Hg reduces the risk of the …

Introduction Schizophrenia is a condition that places a significant burden on individuals with
the condition, their family, and society. A large proportion of those treated for schizophrenia …

Aim To determine whether there is an association between complement factor H (CFH) or
LOC387715 genotypes and response to treatment with photodynamic therapy (PDT) for …